Therefore, the methylation levels of all known MAL2 CpG sites of diverse tissues in TCGA were plotted, and MAL2 cg06822816 (cg7) was selected based on its differential methylation in gliomas versus other cancers (Fig. S3A). Here, MAL2 is linked to glioma.